U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}
structurally diverse
Status:
US Approved Rx (2014)
Source:
BLA125478
(2014)
Source URL:
First marketed in 1924
Source:
BLA103880
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03365336: Not Applicable Interventional Unknown status Influenza
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03366922: Not Applicable Interventional Completed HIV Infections
(2017)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT01057576: Phase 1/Phase 2 Interventional Completed Obesity
(2006)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT00010491: Phase 2 Interventional Completed HIV Infections
(1999)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT04606264: Phase 3 Interventional Not yet recruiting Perioperative Optimization
(2021)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT01674374: Phase 2 Interventional Withdrawn Mucositis
(2013)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT02421770: Phase 3 Interventional Completed Oral Lichen Planus
(2014)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE